logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Amy Frederick

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genzyme Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy Frederick. Retrieved from https://idiyas.com/inventor/amy-frederick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 825 
 
Genzyme Corporation
 patents

Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents
1. 12735459 - MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THERAPY AND METHODS OF USE THEREOF (2026-09-15),

Title: Amy Frederick - Innovator in Gene Therapy

Introduction

Amy Frederick is an inventor based in Hopkinton, MA (US). She is known for her contributions to the field of gene therapy, particularly in the treatment of age-related macular degeneration. Her innovative approach targets complement pathways to address this condition.

Latest Patent Applications

Amy Frederick has submitted a patent application titled "Treatment of Dry Age-Related Macular Degeneration." This application focuses on gene therapy aimed at treating dry age-related macular degeneration by targeting specific biological pathways.

Conclusion

Amy Frederick is making strides in the field of gene therapy, showcasing her commitment to addressing significant health challenges through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…